Full text
Con en s lis s a ailable a ScienceDi ec
Biomedicine & Pha maco he apy
jou nal homepage: www.else ie .com/loca e/biopha
O iginal a icle
Sesqui e penoids and fla onoids om Inula iscosa induce p og ammed cell
dea h in kine oplas ids
Ik ame Zeouk
a,b,c,
*, Ines Si aoui
a,b,d
, A ene i López-A encibia
a,b,d
, Ma ía Reyes-Ba lle
a,b,d
,
Ca los J. Be hencou -Es ella
a,b,d
, Isabel L. Bazzocchi
e
, Khadija Bekh i
c
,
Jacob Lo enzo-Mo ales
a,b,d
, Ignacio A. Jiménez
e
, José E. Piñe o
a,b,d
a
Ins i u o Uni e si a io de En e medades T opicales y Salud Pública de Cana ias, Uni e sidad de La Laguna, A da. As o ísico Fco. Sánchez, S/N, La Laguna, Tene i e,
Islas Cana ias 38203, Spain
b
Red de In es igación Colabo a i a en En e medades T opicales (RICET)
c
Depa emen o Biology, Sidi Mohamed Ben Abdellah Uni e si y, Facul y o Sciences and Techniques, Labo a o y o Mic obial Bio echnology and Bioac i e Molecules, PB
2202, Fez, Mo occo
d
Depa amen o de Obs e icia, Ginecología, Pedia ía, Medicina P e en i a y Salud Pública, Toxicología, Medicina Legal y Fo ense y Pa asi ología, Uni e sidad De La
Laguna, La Laguna, Tene i e, Islas Cana ias 38203, Spain
e
Ins i u o Uni e si a io de Bio-O gánica An onio González, Depa amen o de Química O gánica, Uni e sidad de La Laguna, A enida As o ísico F ancisco Sánchez 2,
38206 La Laguna, Tene i e, Spain
ARTICLE INFO
Keywo ds:
Inula iscosa
Leishmanicidal
T ypanocidal
Sesqui e penoids
Fla onoids
P og ammed cell dea h
ABSTRACT
Neglec ed opical diseases such as leishmaniasis and Ame ican ypanosomiasis ep esen an inc easing heal h
p oblem. Cu en ea men s a e no sa is ac o y which emains an u gen need o no el, cheap and sa e che-
mo he apies. In he cou se o ou ongoing sea ch o new po en ial an i-p o ozoal agen s, his s udy aimed o
pe o m a bio-guided ac iona ion o Inula iscosa (As e aceae) using in i o assays agains h ee s ains o
Leishmania and T ypanosma genus. Eigh known compounds we e iden ified om he e hanolic ex ac o lea es,
sesqui e penoids (3and 4) and fla onoids (5and 6) we e cha ac e ized as he main bioac i e cons i uen s.
Sesqui e pene lac ones 3and 4(IC
50
alues be ween 4.99 and 14.26 μM) showed p omising an ipa asi ic ac i i y
agains p omas igo es o L. dono ani,L. amazonensis and epimas igo es o T. c uzi. Thei s uc u es we e suc-
cess ully cha ac e ized by spec oscopic echniques including 1D and 2D NMR expe imen s. Fu he mo e, he
main bioac i e compounds 4,5and 6displayed highe po ency (IC
50
alues be ween 0.64 and 2.13 μM) agains
amas igo es o L. amazonensis han mil e osine (IC
50
3.11 μM), and a low oxici y on mac ophages cell line
(SI > 45). The analysis o s uc u e-ac i i y ela ionship (SAR) o he an i-p o ozoal ac i i y e ealed ha
lac oniza ion o oxida ion enhanced he biological p ofile, sugges ing ha he hyd ophobic moie y was p e-
sumably in ol ed in he ac i i y by inc easing he affini y and/o cell memb ane pe meabili y. In o de o ge an
insigh in o he mechanism o ac ion o hese compounds, p og ammed cell dea h (PCD) expe imen s we e
pe o med, and he ob ained esul s sugges ha he epo ed compounds induced PCD in he ea ed pa asi es.
These esul s highligh ha sesqui e penoids and fla onoids om I. iscosa could cons i u e an in e es ing
scaffold o he de elopmen o no el an ikine oplas id agen s.
1. In oduc ion
Pa asi ic diseases caused by kine oplas ids such as Leishmania and
T ypanosoma species, known as neglec ed opical diseases (NTDs), a e
esponsible o high mo ali y, disabili y and mo bidi y a es [1]. Ac-
co ding o Wo ld Heal h O ganiza ion (WHO), Ame ican ypanoso-
miasis, also known as Chagas disease, is a po en ially li e- h ea ening
illness caused by he p o ozoan pa asi e T ypanosoma c uzi wi h ap-
p oxima ely mo e han 10 000 dea hs pe yea , and mo e han 25
million people a e a a highe isk o acqui ing his disease [2]. Fu -
he mo e, leishmaniasis is a complex in ec ious disease wi h a a ied
spec um o clinical mani es a ions, which ange om sel -healing cu-
aneous ulce a ion o p og essi e and le hal isce al in ec ion [3]. I is
p e alen in mo e han 98 endemic coun ies in he wo ld wi h an
h ps://doi.o g/10.1016/j.biopha.2020.110518
Recei ed 9 May 2020; Recei ed in e ised o m 24 June 2020; Accep ed 2 July 2020
⁎
Co esponding au ho a : Ins i u o Uni e si a io de En e medades T opicales y Salud Pública de Cana ias, Uni e sidad de La Laguna, A da. As o ísico Fco.
Sánchez, S/N, La Laguna, Tene i e, Islas Cana ias 38203, Spain.
E-mail add ess: [email p o ec ed] (I. Zeouk).
Biomedicine & Pha maco he apy 130 (2020) 110518
A ailable online 13 July 2020
0753-3322/ © 2020 The Au ho s. Published by Else ie Masson SAS. This is an open access a icle unde he CC BY-NC-ND license
(h p://c ea i ecommons.o g/licenses/by-nc-nd/4.0/).
T
es ima ed annual incidence o almos 0.2 o 0.4 million new cases o
isce al mani es a ion and 0.7–1.2 million new cases o cu aneous o m
[4]. The eme gence o esis ance, oxici y and high cos o he cu en
ea men e eal he u gen need o al e na i e chemo he apeu ic
agen s. In his con ex , mo e in e es has been gi en o he de elopmen
o new efficien d ugs using science ad ances such as nano echnology
[5], chemical syn hesis [6] and na u al p oduc s [7]. Among hese
app oaches, plan s p esen a ich sou ce o bioac i e compounds [8].
Fo ins ance, As e aceae amily has mainly p esen ed p omising an i-
pa asi ic ac i i ies agains Leishmania and T ypanosoma genus [9]. Be-
longing o his amily, Inula iscosa also known as Di ichia iscosa is a
medicinal pe ennial he b na i e o he Medi e anean basin and has
been widely used in adi ional medicine o ea diffe en diseases
[10].P e ious chemical in es iga ions ha e cha ac e ized a ious phy-
ochemicals in I. iscosa such as fla onoids, sesqui e penes lac ones,
acids and glycolipids wi h a wide ange o he apeu ic indica ions
[11–13]. Indeed, fla onoids and sesqui e pene lac ones a e a g oup o
na u al p oduc s widely desc ibed as po en an ipa asi ic agen s
[14,15]. Recen ly, que ce in ela ed compounds ha e a ge ed he a -
ginase in Leishmania amazonensis showing a po en ac i i y [16], and
a emisinin which is an illus a i e example o sesqui e pene lac ones,
has displayed an ipa asi ic po ency [17] h ough he induc ion o
apop o ic-like cell dea h [18,19].
Indeed, cell dea h o diffe en de elopmen al s ages o kine oplas-
ids om T ypanosoma and Leishmania genus ha e been coupled o he
occu ence o apop o ic ma ke s such as DNA agmen a ion, cell
sh inkage, ch oma in condensa ion, loss o mi ochond ial memb ane
po en ial ΔΨ and memb ane blebbing [20–22].
Hence, in he p esen wo k we epo a bio-guided ac iona ion o I.
iscosa e hanolic ex ac in o de o cha ac e ize leishmanicidal and
ypanosomal compounds, o elucida e hei mechanism o ac ion a -
ge ing he PCD, and o analyze he s uc u e-ac i i y ela ionship (SAR)
in ol ed in hei an i-p o ozoal ac i i y.
2. Ma e ials and me hods
2.1. Gene al p ocedu e, chemicals and eagen s
Op ical o a ions we e de e mined on a Pe kin-Elme 241 au oma ic
pola ime e . NMR spec a, ROESY (spin lock field 2500 Hz), HSQC and
HMBC (op imized o J =7.7 Hz) we e pe o med on a B uke A ance
500 and 600 spec ome e s a 300°K. Silica gel 60 (pa icle size 15–40
and 63–200 μm, Mache ey-Nagel) was used o column ch oma o-
g aphy, while silica gel 60 F254 (Mache ey-Nagel) was used o ana-
ly ical o p epa a i e TLC and Sephadex LH-20 (Sigma-Ald ich) we e
used o he column ch oma og aphic (CC) sepa a ion. Cen i ugal
p epa a i e TLC was pe o med using a Ch oma o on (Ha ison
Resea ch Inc. model 7924 T) on 4- o 1-mm silica gel 60 PF254 disks
wi h flow a e 2−4 mL min
−1
. The spo s we e isualized by UV ligh
and hea ing silica gel pla es sp ayed wi h H
2
OH
2
SO
4
-AcOH (1:4:20). All
he used sol en s we e analy ical g ade om Pan eac. Reagen s, deu -
e a ed sol en s we e pu chased om Sigma-Ald ich, benznidazole om
Ald ich and mil e osine om Æ e na Zen a is. Fo biological es s,
Schneide ’s medium (Sigma-Ald ich), RPMI 1640 and LIT media
(Gibco®), alama Blue® eagen (In i ogen, Li e Technologies),
EnSpi e®Mul imode Pla e Reade (Pe kin Elme ), and Leika DMIL in-
e ed mic oscope (Leika, We zla , Ge many) we e used.
2.2. Plan ma e ial iden ifica ion and ex ac ion
In he p esen wo k, he s udied plan s ha e been selec ed om an
e hnopha macological s udy unde aken in he cen al no h o
Mo occo. The used pa s o he mos ecommended plan s as desc ibed
by he balis s ha e been collec ed in he A las Moun ains, Imouzze
egion-Mo occo in July 2017, hen iden ified by bo anis s.
In o de o ob ain he c ude ex ac s, cleaned used pa s o he
diffe en plan s we e shade d ied a oom empe a u e and subse-
quen ly milled wi h a simple comme cial elec ic g inde . Powde ed
ma e ial was ex ac ed by mace a ion in e hanol (1:10 w/ ) o 6 h a
oom empe a u e wi h con inuous s i ing a 500 pm ( e olu ions pe
minu e). The esul ing mix u e was fil e ed using Wha man fil e n°1
and he sol en was concen a ed unde acuum in a o a y e apo a o
a 45 °C, d ied ex ac s we e s o ed in a e ige a o a 4 °C un il u he
use. Amongs he six een es ed plan s, I. iscosa ex ac (5 g, 5%) was
he mos ac i e agains he h ee e alua ed pa asi es; he e o e, i was
selec ed o u he bioassays. The geog aphical coo dina es o his
species a e 33°55′37 N, 5°2′50 W and a ouche specimen
(RAB107342) has been deposi ed in he He ba ium o he Scien ific
Ins i u e o Raba , Mo occo.
2.3. Bio-guided ac iona ion p ocedu e
The p epa ed E OH ex ac s we e assayed o hei an ip o ozoal
ac i i y agains p omas igo es o L. amazonensis and L. dono ani and
epimas igo es o T. c uzi. A e ha , a bio-guided ac iona ion me ho-
dology was used o iden i y an ip o ozoal compounds in he e hanolic
ex ac o I. iscosa as he mos ac i e plan . Thus, he ac i e E OH
ex ac (5 g) was subjec ed o CC on silica gel elu ed wi h mix u es o
hexane-E OAc (100:0 o 0:100, 0.5 L each one) o inc easing pola i y o
affo d wel e ac ions ha we e combined in o se en ac ions (F1-F7)
based on hei TLC p ofile. The an ip o ozoal ac i i y was ocused on
he ac i e ac ions F2 (670.6 mg), F3 (871.5 mg) and F4 (1.7155 g),
which we e subjec ed o column ch oma og aphy on sephadex LH-20
column, using a MeOH−CHCl
3
sys em eluen (1:1, 2 L) o affo d be-
ween o y and fi y six sub- ac ions which we e combined again
based on hei TLC p ofiles (F2/1 o F2/5), (F3/1 o F3/6) and (F4/1 o
F4/12), espec i ely. Indeed, he sub- ac ions F3/1 (638.84 mg) and
F3/2 (103.56 mg) showed a p omising ac i i y agains he h ee es ed
s ains and we e subjec ed o mul iple ch oma og aphic s eps on silica
gel, in ol ing medium-p essu e liquid ch oma og aphy, cen i ugal
plana ch oma og aphy and p epa a i e TLC using mix u es o hexane-
E OAc, hexane-E
2
O, CH
2
Cl
2
-E OAc and CH
2
Cl
2
-ace one as eluen o
yield compounds 3(1.78 mg), 4(38.5 mg), 5(3.6 mg) and 7(1.95 mg).
Following he same pu ifica ion p ocedu es, ac ion F2 yielded com-
pounds 1(3.3 mg) and 3, while ac ion F4 affo ded compounds 2
(8.5 mg), 6(28.5 mg) and 8(5.4 mg).
2.4. Leishmanicidal and ypanocidal assays
2.4.1. Pa asi e s ains
The an ipa asi ic ac i i y o c ude ex ac , ac ions and pu e com-
pounds o I. iscosa was e alua ed agains he p omas igo e s age o
Leishmania dono ani (MHOM/IN/90/GE1F8R), p omas igo e and
amas igo e o ms o Leishmania amazonensis (MHOM/BR/77/LTB0016)
and epimas igo e o m o T ypanosoma c uzi (Y s ain).
2.4.2. In i o an ileishmanial e alua ion
2.4.2.1. An i-p omas igo es assay. The bioassay was pe o med using
he alama Blue®me hod as p e iously desc ibed [23]. P omas igo es o
L. dono ani and L. amazonensis we e g own a 26 °C in RPMI 1640
modified medium (Gibco) and supplemen ed wi h 10 % hea -
inac i a ed oe al bo ine se um. Cul u es in he loga i hmic phase
we e seeded in s e ilized 96-well mic o i e pla es (Co ning™) (10
6
pa asi es/mL) con aining he samples dissol ed in dime hyl sul oxide
1% (DMSO) a he sui able concen a ion o be es ed in se ial dilu ions
using Leishmania medium (RPMI 1640) o ge a final olume o 200 μL
pe well, hen 20 μL o alama Blue®we e added o he en i e pla e.
A e an incuba ion o 72 h, he pla e was checked up isually using an
in e ed mic oscope, hen analyzed by an EnSpi e mul imode pla e
eade (Pe kinElme , MA, USA) using a es wa eleng h o 570 nm and
a e e ence wa eleng h o 630 nm. Leishmanicidal ac i i y was
exp essed as IC
50
alues ( he concen a ion o a sample which caused
I. Zeouk, e al. Biomedicine & Pha maco he apy 130 (2020) 110518
2
a 50 % educ ion in pa asi e iabili y). Those alues we e calcula ed by
linea eg ession analysis wi h 95 % confidence limi s.
2.4.2.2. An i-amas igo es assay. The ac i e pu e compounds om I.
iscosa we e es ed agains he in a-mac ophagic s age o L.
amazonensis as p e iously desc ibed in li e a u e [24]. In a 96-well
fla bo om pla e, he J774A.1 cell line mac ophages we e cul u ed a a
densi y o 2 × 10
5
cells/mL in RPMI 1640 medium supplemen ed wi h
10 % hea -inac i a ed oe al bo ine se um and incuba ed o one hou
a 37 °C in a 5 % CO
2
a mosphe e in o de o allow almos comple e
a achmen o he cells. A e ha , mac ophages we e in ec ed wi h L.
amazonensis p omas igo es in he s a iona y phase (7 days old cul u e)
wi h a a io o 1:10 (mac ophage/ pa asi e) a a concen a ion o
2×10
6
cells/mL, hen incuba ed a 37 °C in 5% CO
2
o 24 h. Wells
we e washed wi h medium o emo e non-phagocy osed p omas igo es.
The ea e , he in ec ed mac ophages we e ea ed wi h he pu e
compounds (dissol ed in DMSO a he desi ed concen a ion) o
24 h. The medium was emo ed ca e ully o be eplaced by 30 μLo
0.05 % SDS and he pla e was shaken o 30 s. Subsequen ly, 170 μLo
Schneide ’s medium we e added o each well o gi e a final olume o
200 μL and 20 μL o alama Blue®we e added o he pla e and incuba ed
a 26 °C o 72 h in o de o gi e enough ime o he ans o ma ion
om p omas igo es o amas igo es. A e 72 h o incuba ion, pla es
we e analyzed using he same p o ocol o p omas igo es es .
2.4.3. In i o e alua ion on T. c uzi epimas igo es
The ex ac , ac ions and pu e molecules we e es ed agains he
epimas igo es o T. c uzi. B iefly, in 96-well pla es samples dissol ed in
DMSO we e se ially dilu ed in 100 μL o LIT medium supplemen ed
wi h 10 % hea -inac i a ed e al bo ine se um o ob ain he desi e
concen a ions selec ed om he fi s sc eening. In all es s, 1 % DMSO
was used o dissol e he highes dose o he compounds wi hou indu-
cing any effec s on he pa asi es. A e ha , epimas igo es in loga-
i hmic g ow h phase we e coun ed, adjus ed o 5 × 10
5
cells/mL,
dis ibu ed in he p e ious 96-well pla e and incuba ed a 27 °C o
72 h. The pla e was obse ed unde an in e ed mic oscope a e 72 h o
incuba ion and analyzed s a is ically as desc ibed in he leishmanicidal
es .
2.5. Assessmen o cy o oxici y on mac ophages
The cy o oxici y assay o he pu e ac i e compounds was pe o med
as desc ibed in li e a u e [25]. B iefly, 2 × 10
5
o mac ophages cul u e
we e placed in a 96-well pla e o 2 h in a 5 % CO
2
incuba o a 37 °C,
hen se ial dilu ions o he 4 ac i e molecules we e p epa ed in deep
well, hen ansmi ed o he pla e con aining he cul u e o mac o-
phages gi ing a final olume o 100 μL. Finally, he pla e was incuba ed
in 5 % CO
2
a mosphe e o 24 h. The pe cen age o cell iabili y was
e alua ed using he alama Blue®assay (10 %). Dose esponse cu es
we e plo ed and he CC
50
alues we e calcula ed.
2.6. Mechanisms o cell dea h
In o de o analyze he p og ammed cell dea h pa hway induced in
he s udied pa asi es, a common s ep be ween he ou ki s was pe -
o med. B iefly, pa asi es we e ea ed wi h he es ed compounds a
hei IC
90
o 24 h. A e ha , cells we e cen i uged (1500 pm o
10 min), washed wice wi h PBS (phospha e buffe ed saline) and in-
cuba ed wi h he sui able eagen o each ma ke as desc ibed below.
Fo he ou assays, an un ea ed con ol was used. A e incuba ions, an
EVOS FL Cell Imaging Sys em AMF4300, Li e Technologies, Mad id,
Spain was used o obse e and analyze he ob ained esul s in o de o
sco e and o coun cells.
2.6.1. Ch oma in condensa ion de e mina ion
To analyze he compac ed s a e o ch oma in in apop o ic cells, a
double-s ain apop osis de ec ion ki (Hoechs 33342/PI) (Li e
Technologies) was used as ecommended by he manu ac u e . The
s ains we e incuba ed wi h Hoechs 33342 a 5 μg/mL and PI a 1 μg/
mL. A e 15 min o incuba ion a 26 °C, samples we e analyzed.
2.6.2. Analysis o mi ochond ial memb ane po en ial
The JC-1 Mi ochond ial Memb ane Po en ial Assay Ki (Cayman
Chemical) was used o measu e he collapse o an elec ochemical
g adien ac oss he mi ochond ial memb ane. T ea ed p omas igo es e-
suspended in JC-1 buffe we e incuba ed wi h JC-1 eagen (1:10 / )
and hen incuba ed a 26 °C o 30 min. Analysis o mean g een and ed
fluo escence in ensi y and depola iza ion o he mi ochond ial mem-
b ane po en ial was analyzed.
2.6.3. De e mina ion o ATP le el
ATP le el was measu ed using a Cell Ti e -Glo®Luminescen Cell
Viabili y Assay (P omega). The effec o he compounds on he ATP
p oduc ion was e alua ed by incuba ing pa asi ic s ains (10
6
cells/mL)
wi h he es ed molecules a hei IC
90
o 24 h.
2.6.4. Plasma memb ane pe meabili y
To de ec he plasma memb ane pe meabili y o pa asi es, he
SYTOX®G een assay was pe o med. The ea ed pa asi es we e in-
cuba ed wi h SYTOX®G een a a final concen a ion o 1 μM (Molecula
P obes) o 15 min in he da k a oom empe a u e. The inc ease in
fluo escence due o binding o he fluo escen ma ke o he pa asi ic
DNA was obse ed.
2.6.5. Oxida i e s ess
CellRox Deep Red Oxida i e S ess Reagen (The mo Fishe
Scien ific) was used o measu e he gene a ion o Reac i e Oxygen
Species (ROS) in cells exhibi ing s ong fluo ogenic signal unde oxi-
da i e s a e. The assay in ol es he incuba ion o he ea ed pa asi es
wi h 5 μM o CellRox Reagen o 30 min a 26 °C, hen he cen-
i uga ion o cells o be e-suspended in buffe . H
2
O
2
a 600 μM o
30 min was used as posi i e con ol. The signal o Deep Red is localized
in he cy oplasm.
Table 1
Leishmanicidal and ypanosomal ac i i y agains p omas igo es o L. amazo-
nensis and L. dono ani and epimas igo es o T. c uzi o he ex ac , ac ions and
sub- ac ions om lea es o I. iscosa.
Samples L. amazonensis
IC
50
(μg/mL)
L. dono ani
IC
50
(μg/mL)
T. c uzi
IC
50
(μg/mL)
C ude ex ac 18.10 ± 2.08 10.87 ± 2.11 12.18 ± 0.50
F2 35.66 ± 1.78 31.07 ± 2.17 8.67 ± 0.45
F2/4 15.95 ± 0.80 52.95 ± 3.18 13.74 ± 0.96
F3 3.80 ± 0.23 4.48 ± 0.15 6.61 ± 0.87
F3/1 6.44 ± 0.02 7.71 ± 2.46 9.04 ± 1.86
F3/2 12.72 ± 1.27 10.66 ± 2.35 23.93 ± 1.91
F4 3.63 ± 0.14 27.12 ± 01.27 27.00 ± 0.87
F4/3 15.46 ± 0.75 12.52 ± 0.42 11.18 ± 1.13
F4/4 17.85 ± 0.85 6.6 ± 1.22 10.76 ± 2.12
F4/5 12.77 ± 0.05 9.08 ± 0.66 8.59 ± 1.58
F4/6 19.60 ± 2.65 18.01 ± 0.90 9.89 ± 0.08
F4/7−9 13.03 ± 1.11 10.76 ± 2.90 5.41 ± 1.38
F4/10 32.17 ± 1.93 36.62 ± 1.46 22.13 ± 1.90
F4/10/1 7.64 ± 0.86 7.93 ± 0.15 2.20 ± 0.49
Mil e osine 2.64 ± 0.10 1.35 ± 0.11 –
Benznidazole –– 1.81 ± 0.50
IC
50
: Inhibi o y Concen a ion ha inhibi s 50 % o he g ow h o he es ed
pa asi e.
IC
50
: Means ±S anda d de ia ion.
F ac ions and sub- ac ions ha showed IC
50
> 100 μg/mL we e excluded.
I. Zeouk, e al. Biomedicine & Pha maco he apy 130 (2020) 110518
3
2.7. S a is ical analysis
All assays we e ca ied ou in iplica e. The esul s we e defined as
he mean alues o h ee expe imen s. The ob ained inhibi ion cu es
was pe o med using he Sigma Plo 12.0 so wa e p og am (Sys a
So wa e Inc.). S a is ical analyses we e pe o med using he G aphPad
P ism 8.0.2. Fluo escence in ensi y (RFU) was pe o med using ImageJ
so wa e p og am as he means alues o h ee epe i ions. Diffe ences
be ween he alues we e assessed using a one-way analysis o a iance
(ANOVA). Da a a e p esen ed as means ± SD and p< 0.05 was
conside ed s a is ically significan .
Fig. 1. Flowcha o an ip o ozoal bio-guided ac iona ion o Inula iscosa lea es agains p omas igo es o L. amazonensis and L. dono ani and epimas igo es o T.
c uzi (Tc). IC
50
: Inhibi o y concen a ion ha inhibi s 50 % o he g ow h o he es ed pa asi e. IC
50
alues in μg/mL.
Fig. 2. Chemical s uc u e o na u al compounds 1-8isola ed om lea es o Inula iscosa.
I. Zeouk, e al. Biomedicine & Pha maco he apy 130 (2020) 110518
4
3. Resul s and discussion
3.1. An ikine oplas id ac i i y
Resea ch on an ikine oplas id d ugs has been in ensified in ecen
yea s exploi ing na u al p oduc s om medicinal plan s [26,27]. The
leishmanicidal and ypanosomal ac i i ies o plan ex ac s ha e been
a ibu ed o se e al compounds belonging o diffe en chemical g oups
such as mono e penes, i e penes, alkaloids, lignans and fla onoids
[28–30]. In special, sesqui e penoids and fla onoids isola ed om
a ious plan s ha e widely exhibi ed a p ominen leishmanicidal [31]
and ypanocidal ac i i y [32]. In he p esen wo k, e hanolic ex ac s
o six een plan s used in adi ional medicine o ea men o in ec ious
diseases such as skin diso de s, in he cen al no h o Mo occo, we e
e alua ed. Roo s o Alkanna in o ia,Be be is hispanica,Ephed a al issima
and Rubia inc o ium; ae ial pa s o C a aegus oxyacan ha and U ica
dioica; lea es o Ammi majus, Globula ia alypum,Inula iscosa,La andula
den a a,Ne ium oleande ,O iganum majo ana, and Rhamnus ala e nus;
seeds o E uca sa i a and Junipe us oxyced us and peel o Punica g an-
a um. The ex ac s we e fi s ly sc eened a 400, 200, 100; 50 and 25 μg/
mL agains p omas igo e s age o L. dono ani and L. amazonensis, and
epimas igo e o m o T. c uzi. The c ude e hanolic ex ac o I. iscosa
showed he mos in e es ing ac i i y agains he es ed s ains, wi h
IC
50
s be ween 10.87 and 18.10 μg/mL (Table 1) which was a p omising
ac o con inue wi h he bioassay-guided ac iona ion in o de o
isola e and iden i y he main ac i e molecules in ol ed in he an i-
pa asi ic effec s. The e o e, he e hanolic ex ac was submi ed o li-
quid ch oma og aphy on silica gel affo ding six ac ions, F1-F6 (Fig. 1).
Indeed, samples ha led o a pe cen age o g ow h inhibi ion
(%GI) > 50 % we e assayed in diffe en concen a ions o de e mine
he hal maximal inhibi o y concen a ion (IC
50
) and we e classified as
highly ac i e (IC
50
<25μg/mL), ac i e (25 < IC
50
<50μg/mL),
mode a ely ac i e (50 < IC
50
< 100 μg/mL) and no ac i e when
IC
50
> 100 μg/mL. In addi ion, mil e osine and benznidazole we e
e alua ed o compa a i e pu poses as e e ence d ugs agains leish-
maniasis and Chagas disease espec i ely. Mil e osine showed IC
50
so
2.64 μg/mL and 1.35 μg/mL agains L. amazonensis and L. dono ani,
espec i ely, whe eas benznidazole showed an IC
50
o 1.81 μg/mL
agains T. c uzi.
The IC
50
alues a ied upon he ac ions and he pa asi ic s ains
showing diffe en magni udes o he inhibi o y po en ial. The mos
ac i e ac ions, F2 (IC
50
alues anging om 8.67 o 35.66 μg/mL), F3
(IC
50
alues anging om 3.80 o 6.61 μg/mL) and F4 (IC
50
alues
anging om 3.63 o 27.12 μg/mL), exhibi ed po en ac i i y agains
he h ee s udied pa asi es, simila o he e e ence d ugs (Table 1 and
Fig. 1), highligh ing hese h ee ac ions as he mos p omising ones.
Subsequen ly, hese ac ions we e u he ch oma og aphed on a se-
phadex LH-20 column yielding fi e (F2/1-F2/5), six (F3/1-F3/6) and
en sub- ac ions (F4/1-F4/10), espec i ely, which we e assayed
agains he h ee pa asi es. F om F ac ion 2, F2/4 exhibi ed a po en
an ikine oplas id effec on L. amazonensis (IC
50
15.95 μg/mL) and T.
c uzi (IC
50
13.74 μg/mL). F om ac ion F3, sub- ac ions F3/1 and F3/2
we e he mos ac i es agains he h ee pa asi es, showing IC
50
s be-
ween 6.44 and 12.72 μg/mL o L. amazonensis and L. dono ani, e-
spec i ely, and an IC
50
o 9.04 μg/mL on T. c uzi o F3/1.While om
ac ion F4, sub- ac ions F4/3, F4/4, F4/5 and F4/6 we e he mos
ac i es agains he h ee pa asi es, showing IC
50
s be ween 6.60 and
19.60 μg/mL o L. amazonensis and L. dono ani, espec i ely and IC
50
s
be ween 8.59 and 11.18 μg/mL o T. c uzi. The e o e, sub- ac ion F2/
4 was submi ed o pu ifica ion s eps, affo ding he sesqui e penoids 1
and 3. Addi ionally, sub- ac ion F3/1 showed o be he mos po en
one, yielding he compound 3and sub- ac ion F3/2 affo ded
Table 2
Leishmanicidal, ypanocidal, cy o oxic ac i i y and selec i i y index agains p omas igo es o Leismania spp., epimas igo es o T. c uzi and mu ine mac ophages o
he ac i e sesqui e penoids and fla onoids isola ed om I. iscosa.
Compounds L. amazonensis L. dono ani T. c uzi Mu ine mac ophages
IC
50
(μM) SI IC
50
(μM) SI IC
50
(μM) SI CC
50
(μM)
3 9.53 ± 2.44 1.92 11.06 ± 2.33 1.66 4.99 ± 0.04 3.67 18.44 ± 1.30
4 12.12 ± 0.64 3.50 14.26 ± 1.69 2.97 12.52 ± 0.16 3.38 42.36 ± 2.54
5 81.08 ± 3.24 1.18 86.45 ± 2.60 1.11 36.17 ± 2.17 2.65 95.93 ± 0.50
6 44.86 ± 2.95 > 7.73 54.46 ± 2.36 > 6.3 82.95 ± 1.65 > 4.18 > 100
Mil e osine 6.48 ± 0.24 11.14 3.31 ± 0.27 21.79 ––72.18 ± 1.25
Benznidazole ––––6.95 ± 1.92 57.51 399.91 ± 1.04
IC
50
: Inhibi o y Concen a ion ha inhibi s 50 % o he g ow h o he es ed pa asi e.
IC
50
: Means ±S anda d de ia ion.
CC
50
: Cy o oxic Concen a ion ha educes 50 % o he mu ine mac ophages’ iabili y.
SI: Selec i i y Index (CC
50
/IC
50
).
Compounds ha showed IC
50
> 100 μM we e excluded.
Table 3
Leishmanicidal ac i i y and selec i i y index o selec compounds agains
amas igo e s age o L. amazonensis.
Compounds L. amazonensis
IC
50
(μM)
SI
a
3 6.98 ± 0.42 2.63
4 0.64 ± 0.08 65.75
5 2.13 ± 1.21 45.00
6 1.91 ± 0.83 > 181.81
Mil e osine 3.11 ± 0.29 23.16
IC
50
: Inhibi o y Concen a ion ha inhibi s 50 % o he g ow h o he es ed
pa asi e.
IC
50
: Means ±S anda d de ia ion.
CC
50
: Cy o oxic Concen a ion ha educes 50 % o he mu ine mac ophages’
iabili y.
SI
a
: Selec i i y Index (amas igo es) (CC
50
/IC
50
).
Table 4
Leishmanicidal and ypanocidal ac i i y o he selec ed compounds o s udy o
mechanism o ac ion.
Compounds IC
90
(μM)
L. dono ani L. amazonensis T. c uzi
3 76.25 ± 3.05 12.85 ± 1.07 17.00 ± 0.33
4 94.23 ± 0.57 48.53 ± 0.18 22.11 ± 0.30
5 107.66 ± 1.76 322.42 ± 0.97 191.68 ± 0.77
6 135.57 ± 0.20 158.23 ± 3.37 173.45 ± 0.61
Mil e osine 5.15 ± 0.50 9.63 ± 0.50 –
Benznidazole ––25.591 ± 2.728
IC
90
:Effec i e Concen a ion ha inhibi s 90 % o he g ow h o he es ed
pa asi e.
IC
90
: Means ±S anda d de ia ion.
I. Zeouk, e al. Biomedicine & Pha maco he apy 130 (2020) 110518
5
compounds 4,5and 7. Sub- ac ion F4/10 yielded compounds 2,6and
8(Figs. 1,2). Hence, in some cases, he IC
50
was highe han he c ude
ex ac which could be explained by a possible syne gism be ween I.
iscosa componen s since he complex mix u es o plan componen s
may p o ide diffe en ou comes: an addi i e, a syne gis ic o an an-
agonis ic effec . The chemical s uc u es o he known isola ed
Fig. 3. Leishmania amazonensis p omas igo es incuba ed wi h IC
90
o he ou ac i e compounds o 24 h: Inuloxin A (B,G,L), saku ane in (C,H,M), 8-epi-xan ha in-
1β,5β-epoxide (D,I,N), axi olin (E,J,O). Images (40X) a e ep esen a i e o he cell popula ion obse ed in he pe o med expe imen s using an EVOS FL Cell
Imaging Sys em AMF4300, Li e Technologies, USA. Hoechs s ain is diffe en when compa ing nega i e con ol (A,F,K) wi h ea ed cells whe e he nuclei a e b igh
blue. Red fluo escence co esponds o he p opidium iodide s ain. Hoechs s ain (F-J), P opidium iodide s ain (K-O). The ba g aph includes he calcula ed alues o
RFU (Fluo escence in ensi y). Diffe ences be ween he alues we e assessed using one-way analysis o a iance (ANOVA). Da a a e p esen ed as means ± SD (N = 3)
and le e s a-e o A*-E* eflec ha means wi hin compounds wi h diffe en le e s a e significan ly diffe en (p< 0.05). (Fo in e p e a ion o he e e ences o
colou in he Figu e, he eade is e e ed o he web e sion o his a icle).
Fig. 4. Images (40X) ob ained om an EVOS FL Cell Imaging Sys em showing fluo escence when p omas igo es o Leishmania dono ani incuba ed wi h IC
90
o he
ou es ed compounds o 24 h: Inuloxin A (B,G,L), saku ane in (C,H,M), 8-epi-xan ha in-1β,5β-epoxide (D,I,N), axi olin (E,J,O) and s ained wi h Hoechs -
p opidium iodide. Hoechs co esponds o he ch oma in condensa ion (blue) in ea ed cells. Red fluo escence co esponds o he p opidium iodide s ain. A con ol
wi hou ea men has been used (A,F,K). The ba g aph includes he calcula ed alues o RFU (Fluo escence in ensi y). Diffe ences be ween he alues we e
assessed using one-way analysis o a iance (ANOVA). Da a a e p esen ed as means ± SD (N = 3) and le e s a-e o A*-E* eflec ha means wi hin compounds wi h
diffe en le e s a e significan ly diffe en (p< 0.05). (Fo in e p e a ion o he e e ences o colou in he Figu e, he eade is e e ed o he web e sion o his
a icle).
Fig. 5. Images (40X) ob ained om EVOS FL Cell Imaging Sys em showing he effec o Inuloxin A (B,G,L), saku ane in (C,H,M), 8-epi-xan ha in-1β,5β-epoxide (D,
I,N), axi olin (E,J,O) a he IC
90
agains epimas igo es o T ypanosoma c uzi a e 24 h o incuba ion in compa ison o he con ol (A,F,K), hen using Hoechs -
p opidium iodide double s ains. Hoechs co esponds o he ch oma in condensa ion (blue) in ea ed cells. Red fluo escence co esponds o he p opidium iodide
s ain. The ba g aph includes he calcula ed alues o RFU (Fluo escence in ensi y). Diffe ences be ween he alues we e assessed using one-way analysis o a iance
(ANOVA). Da a a e p esen ed as means ± SD (N = 3) and le e s a-e o A*-E* eflec ha means wi hin compounds wi h diffe en le e s a e significan ly diffe en
(p< 0.05). (Fo in e p e a ion o he e e ences o colou in he Figu e, he eade is e e ed o he web e sion o his a icle).
I. Zeouk, e al. Biomedicine & Pha maco he apy 130 (2020) 110518
6
compounds (1-8) we e iden ified as isocos ic acid (1)[33], ilicic acid
(2)[34], 8-epi-xan ha in-1β,5β-epoxide (3)[35], inuloxin A (4)[36],
saku ane in (5)[37], axi olin (6)[38], 3-O-ace yl-7-O-me hyla -
omadend in (7)[38], and que ce in (8)[39] using spec ome ic and
spec oscopic da a, including 1D and 2D NMR expe imen s, in addi ion
o compa ison wi h da a epo ed in he li e a u e. Compounds 1-8
we e e alua ed agains he h ee pa asi es. In addi ion, he cy o oxici y
on mu ine mac ophages was also assessed. Mil e osine showed a CC
50
o 72.18 μM, whe eas benznidazole showed a CC
50
o 399.91 μM
(Table 2). The esul s, o e he p omas igo e s age o Leishmania,
showed ha compounds 3and 4displayed po en ac i i y in μM ange
and we e sligh ly less po en han he e e ence d ug. Mo eo e , com-
pounds 3and 4showed simila po ency o benznidazole agains epi-
mas igo es o T. c uzi. Rega ding he selec i i y index (SI) owa ds
mac ophages (Table 2), he compounds 3and 4showed a mode a ed
cy o oxic p ofile on he h ee pa asi es (SI alues anging om 1.66 o
3.67). Based on he in i o esul s on p omas igo e o ms, compounds
3-6we e selec ed o be e alua ed on in acellula amas igo es o L.
amazonensis. The esul s e ealed ha compounds (4-6) exhibi ed
highe po ency han mil e osine (IC
50
3.11 μM), showing IC
50
alues
om 0.64 o 2.13 μM. In ac , sesqui e pene lac one 4was 4.8- old mo e
po en han he e e ence d ug. Besides, he h ee compounds showed
highe selec i i y index han mil e osine (Table 3), highligh ing com-
pound 6wi h a SI o 181.81 e sus 23.16 o mil e osine.
To he bes o ou knowledge, only one in es iga ion desc ibed he
leishmanicidal effec o I. iscosa whe e se ies o inuloxin de i a i es
we e e alua ed agains p omas igo es o L. dono ani [40]. Simila o ou
finding, compound 4displayed impo an an ipa asi ic ac i i y (6.89
μM). Based on li e a u e, he e a e no in es iga ions ha epo ed he
ac i i y o his compound agains nei he amas igo e o m no o he
Leishmania spp. o T. c uzi. In addi ion, he cha ac e iza ion o he
sesqui e pene lac one 3in I. iscosa is desc ibed o he fi s ime and
when isola ed om o he plan species, i was epo ed as he mos
ac i e agains T. c uzi and L. dono ani [41,42]. Fu he mo e, he esul s
ob ained in he cu en s udy confi m he no ewo hy leishmanicidal
and ypanosomal po ency o compounds 5and 6commonly ound in I.
Fig. 6. The effec o inuloxin A (B,G,L), saku ane in (C,H,M), 8-epi-xan ha in-1β,5β-epoxide (D,I,N), axi olin (E,J,O) on he mi ochond ial po en ial o
Leishmania amazonensis p omas igo es compa ed o he con ol (A,F,K). JC-1 dye accumula es in he mi ochond ia o heal hy cells as agg ega es ( ed fluo escence) in
cells ea ed wi h he IC
90
o compounds o 24 h, due o collapse o mi ochond ial po en ial, he JC-1 dye emained in he cy oplasm in i s monome ic o m, g een
fluo escence. Images (40X) a e ep esen a i e o he pa asi es obse ed in he pe o med expe imen s using an EVOS FL Cell Imaging Sys em. The ba g aph includes
he calcula ed alues o RFU (Fluo escence in ensi y). Diffe ences be ween he alues we e assessed using one-way analysis o a iance (ANOVA). Da a a e p esen ed
as means ± SD (N = 3) and le e s a-e o A*-E* eflec ha means wi hin compounds wi h diffe en le e s a e significan ly diffe en (p< 0.05). (Fo in e p e a ion
o he e e ences o colou in he Figu e, he eade is e e ed o he web e sion o his a icle).
Fig. 7. Images (40X) ob ained om EVOS FL Cell Imaging Sys em showing he effec o IC
90
o inuloxin A (B,G,L), saku ane in (C,H,M), 8-epi-xan ha in-1β,5β-
epoxide (D,I,N), axi olin (E,J,O) on he mi ochond ial po en ial o T ypanosoma c uzi epimas igo es compa ed o he con ol (A,F,K) using JC1 ki s a e 24 h o
incuba ion. The ba g aph includes he calcula ed alues o RFU (Fluo escence in ensi y). Diffe ences be ween he alues we e assessed using one-way analysis o
a iance (ANOVA). Da a a e p esen ed as means ± SD (N = 3) and le e s a-e o A*-E* eflec ha means wi hin compounds wi h diffe en le e s a e significan ly
diffe en (p< 0.05).
I. Zeouk, e al. Biomedicine & Pha maco he apy 130 (2020) 110518
7
Fig. 8. Leishmania dono ani (40X) s ained wi h JC-1 ki s a e 24 h incuba ion o p omas igo es wi h IC
90
o inuloxin A (B,E,H) and saku ane in (C,F,I). Images
(40X) a e ep esen a i e o he effec on he mi ochond ial po en ial o he pa asi es and obse ed using an EVOS FL Cell Imaging Sys em. A con ol wi hou
ea men has been used (A,D,G). The ba g aph includes he calcula ed alues o RFU (Fluo escence in ensi y). Diffe ences be ween he alues we e assessed using
one-way analysis o a iance (ANOVA). Da a a e p esen ed as means ± SD (N = 3) and le e s a-e o A*-E* eflec ha means wi hin compounds wi h diffe en
le e s a e significan ly diffe en (p< 0.05).
Fig. 9. The effec o 8-epi-xan ha in-1β,5β-epoxide (3), inuloxin A (4), saku ane in (5) and axi olin (6) on he ATP p oduc ion o Leishmania amazonensis (A),
Leishmania dono ani (B) and T ypanosoma c uzi (C), using CellTi e -Glo Luminescen Cell Viabili y Assay. Resul s a e ep esen ing in pe cen age ela i e o he
nega i e con ol. Cells we e ea ed by he IC
90
concen a ion o 24 h. Values a e gi en as mean ± SD (N = 3). a-e: means wi hin compounds wi h diffe en le e s
a e significan ly diffe en (p< 0.05).
I. Zeouk, e al. Biomedicine & Pha maco he apy 130 (2020) 110518
8
iscosa [43,44].
The influence o he subs i u ion pa e n in he sesqui e pene and
fla onoid skele on on he an ikine oplas id ac i i y was s udied, e-
ealing he ollowing ends on he p elimina y s uc u e-ac i i y e-
la ionship o hese na u al compounds. In one hand, he influence o he
subs i u ion pa e n in he sesqui e pene scaffold on he an i-
kine oplas id ac i i y seems o be linked o he lac one ing (3and 4
e sus 1and 2) which is a c i ical unc ional g oup o he ac i i y.
P e ious da a demons a ed he essen ial unc ion o u anone ing in
he biological ac i i ies [40,45]. On he o he hand, he SAR analysis o
he fla onoids showed ha he o e all oxida ion le el a e impo an
ends o his se ies, compound 6con aining fi e oxygena ed posi ions
has inc eased po ency compa ed o hei pa en compounds 5and 8.
Mo eo e , he ace yla ion and me hyla ion e ealed de imen al effec
on he ac i i y, when compa ing effec o compound 6 o ha o com-
pound 7. These esul s highligh ed ha he bes unc ional g oup is he
hyd oxyl, which can ac as an H-bond dono sugges ing ha he hy-
d ophilici y o he molecule con ibu es o i s biological ac i i y. P e-
ious in es iga ions confi med ha he hyd ophobic cha ac e o mo-
lecules dec eases he cell pe meabili y o he a ge eflec ing a weak
ac i i y [46]. In he same ein, i was sugges ed ha he associa ion o
hyd oxyl g oup a C-4′associa ed o one me hoxyl g oup a C-7 in
compound 5is necessa y o he an ipa asi ic po ency [47]. The p e-
sence o such g oups could cons i u e in e es ing si es o in e ac ion
and/o eac ion ela ed o he an ipa asi ic ac i i y. Fu he mo e,
cha ac e is ics such as ace yla ion we e in ol ed in a be e anspo
and dis ibu ion in he biological sys em which enhanced he
leishmanicidal effec [48].
3.2. P og ammed cell dea h pa hway
Resul s ob ained om he in i o an ipa asi ic ac i i ies and he
selec i i y index o compounds o e amas igo e s age (Tables 2 and 3),
we e encou aging o analyze hei possible mechanism o ac ion.
(Table 4). Indeed, cell dea h o diffe en de elopmen al s ages o ki-
ne oplas ids such as T ypanosoma and Leishmania genus we e coupled o
he occu ence o apop o ic e en s [20]. Among he mos ele an
apop o ic pheno ypes o Leishmania spp. and T ypanosoma spp., he e
a e DNA agmen a ion, cell sh inkage, plasma memb ane modifica-
ions and mi ochond ial depola iza ion [21,49]. Hence, in he p esen
wo k, diffe en expe imen s we e in es iga ed in o de o ob ain in-
sigh s in o he apop o ic po en ial o he ou ac i e compounds agains
L. dono ani,L. amazonensis and T. c uzi.
We fi s analyzed he DNA condensa ion ha p o ides e idence o
dea h h ough apop osis. The p ope ies o he pe o med assay indica e
ha a no mal s a e o ch oma in allows ligh blue when cells s ained
wi h Hoechs 33,342, while he ea ly s ained apop o ic cells show
b igh blue nuclei co esponding o ch oma in condensa ion. While, PI
was used o s ain he dead cells showing dense b igh ed nuclei. The
s aining pa e n esul ed om his ki leads o dis inguish no mal,
apop o ic and dead pa asi es. As displayed in Figs. 3,4,5, he ea -
men o L. amazonensis wi h compounds 3–6induced a highly no ice-
able condensa ion o ch oma in, compa ed wi h he con ol (p< 0.05).
Mo eo e , he ed fluo escence indica ed ha PI pene a ed he cell
Fig. 10. Images (40X) p esen ing he effec s o IC
90
concen a ion o inuloxin A (B, G), saku ane in (C, H), 8-epi-xan ha in-1β,5β-epoxide (D, I) and axi olin (E, J) on
he plasma memb ane pe meabili y o Leishmania amazonensis p omas igo es a e 24 h incuba ion. Cells we e labeled wi h Sy ox®G een. Images we e ob ained using
an EVOS FL Cell Imaging Sys em and un ea ed s ains we e used as nega i e con ol (A, F). The ba g aph includes he calcula ed alues o RFU (Fluo escence
in ensi y). Diffe ences be ween he alues we e assessed using one-way analysis o a iance (ANOVA). Da a a e p esen ed as means ± SD (N = 3) and le e s a-e
eflec ha means wi hin compounds wi h diffe en le e s a e significan ly diffe en (p< 0.05). (Fo in e p e a ion o he e e ences o colou in he Figu e, he
eade is e e ed o he web e sion o his a icle).
I. Zeouk, e al. Biomedicine & Pha maco he apy 130 (2020) 110518
9